Michaël Hocquemiller

882 total citations
17 papers, 642 citations indexed

About

Michaël Hocquemiller is a scholar working on Physiology, Molecular Biology and Epidemiology. According to data from OpenAlex, Michaël Hocquemiller has authored 17 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 8 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Michaël Hocquemiller's work include Lysosomal Storage Disorders Research (12 papers), Cellular transport and secretion (6 papers) and Trypanosoma species research and implications (6 papers). Michaël Hocquemiller is often cited by papers focused on Lysosomal Storage Disorders Research (12 papers), Cellular transport and secretion (6 papers) and Trypanosoma species research and implications (6 papers). Michaël Hocquemiller collaborates with scholars based in France, United States and Australia. Michaël Hocquemiller's co-authors include Samantha Parker, Nathalie Cartier, Mickaël Audrain, Jean‐Michel Heard, Jérôme Ausseil, Sandrine Vitry, Jean Michel Heard, Stéphanie Bigou, Olivier Danos and Ronald G. Crystal and has published in prestigious journals such as American Journal Of Pathology, Stem Cells and Experimental Neurology.

In The Last Decade

Michaël Hocquemiller

16 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michaël Hocquemiller France 12 365 268 253 123 102 17 642
Heather Gray‐Edwards United States 17 540 1.5× 397 1.5× 276 1.1× 114 0.9× 129 1.3× 51 870
Sara Marcó Spain 11 239 0.7× 240 0.9× 368 1.5× 124 1.0× 148 1.5× 14 580
Jessica Bagel United States 18 435 1.2× 378 1.4× 555 2.2× 153 1.2× 192 1.9× 31 1.0k
Nathalie Desmaris France 8 316 0.9× 305 1.1× 432 1.7× 151 1.2× 199 2.0× 8 697
Michael K. Parente United States 11 334 0.9× 275 1.0× 175 0.7× 70 0.6× 97 1.0× 14 555
Armida Faella United States 10 426 1.2× 332 1.2× 169 0.7× 56 0.5× 123 1.2× 14 793
Alessia Capotondo Italy 11 362 1.0× 240 0.9× 240 0.9× 60 0.5× 83 0.8× 16 732
Abdi Ghodsi United States 6 442 1.2× 438 1.6× 172 0.7× 55 0.4× 125 1.2× 6 708
Ashley N. Randle United States 11 187 0.5× 148 0.6× 218 0.9× 89 0.7× 86 0.8× 17 365
Béatrice Joussemet France 6 413 1.1× 373 1.4× 132 0.5× 40 0.3× 84 0.8× 9 642

Countries citing papers authored by Michaël Hocquemiller

Since Specialization
Citations

This map shows the geographic impact of Michaël Hocquemiller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaël Hocquemiller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaël Hocquemiller more than expected).

Fields of papers citing papers by Michaël Hocquemiller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaël Hocquemiller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaël Hocquemiller. The network helps show where Michaël Hocquemiller may publish in the future.

Co-authorship network of co-authors of Michaël Hocquemiller

This figure shows the co-authorship network connecting the top 25 collaborators of Michaël Hocquemiller. A scholar is included among the top collaborators of Michaël Hocquemiller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaël Hocquemiller. Michaël Hocquemiller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Bugiani, Marianna, Truus E. M. Abbink, Arthur W. D. Edridge, et al.. (2023). Focal lesions following intracerebral gene therapy for mucopolysaccharidosis IIIA. Annals of Clinical and Translational Neurology. 10(6). 904–917. 6 indexed citations
3.
Pokorná, Šárka, Olga Khersonsky, Rosalie Lipsh‐Sokolik, et al.. (2023). Design of a stable human acid‐β‐glucosidase: towards improved Gaucher disease therapy and mutation classification. FEBS Journal. 290(13). 3383–3399. 8 indexed citations
4.
Tabet, Ricardos, Fabrice Riet, Doulaye Dembélé, et al.. (2022). AAV‐delivered diacylglycerol kinase DGKk achieves long‐term rescue of fragile X syndrome mouse model. EMBO Molecular Medicine. 14(5). e14649–e14649. 12 indexed citations
5.
Hocquemiller, Michaël, Amanda L. Gross, Ashley N. Randle, et al.. (2022). AAVrh10 vector corrects pathology in animal models of GM1 gangliosidosis and achieves widespread distribution in the CNS of nonhuman primates. Molecular Therapy — Methods & Clinical Development. 27. 281–292. 11 indexed citations
6.
O’Leary, Claire, José A. G. Agúndez, Helen Parker, et al.. (2019). An improved AAV vector for neurological correction of the mouse model of Mucopolysaccharidosis IIIA. UCL Discovery (University College London). 1 indexed citations
7.
Hocquemiller, Michaël, Kim M. Hemsley, Daniel Neumann, et al.. (2019). AAVrh10 Vector Corrects Disease Pathology in MPS IIIA Mice and Achieves Widespread Distribution of SGSH in Large Animal Brains. Molecular Therapy — Methods & Clinical Development. 17. 174–187. 25 indexed citations
8.
Gray, Anna L., Claire O’Leary, Aiyin Liao, et al.. (2019). An Improved Adeno-Associated Virus Vector for Neurological Correction of the Mouse Model of Mucopolysaccharidosis IIIA. Human Gene Therapy. 30(9). 1052–1066. 14 indexed citations
9.
Laufer, Ralph, Michaël Hocquemiller, & Kim M. Hemsley. (2019). AAV gene therapy LYS-SAF302 demonstrates widespread sulfamidase distribution in primate brain and correction of disease pathology in MPS IIIA mice. Molecular Genetics and Metabolism. 126(2). S91–S92. 1 indexed citations
10.
Hocquemiller, Michaël, et al.. (2016). Adeno-Associated Virus-Based Gene Therapy for CNS Diseases. Human Gene Therapy. 27(7). 478–496. 210 indexed citations
12.
Vitry, Sandrine, Julie Bruyère, Michaël Hocquemiller, et al.. (2010). Storage Vesicles in Neurons Are Related to Golgi Complex Alterations in Mucopolysaccharidosis IIIB. American Journal Of Pathology. 177(6). 2984–2999. 35 indexed citations
13.
Vitry, Sandrine, et al.. (2009). Enhanced degradation of synaptophysin by the proteasome in mucopolysaccharidosis type IIIB. Molecular and Cellular Neuroscience. 41(1). 8–18. 32 indexed citations
14.
Hocquemiller, Michaël, Sandrine Vitry, Stéphanie Bigou, et al.. (2009). GAP43 overexpression and enhanced neurite outgrowth in mucopolysaccharidosis type IIIB cortical neuron cultures. Journal of Neuroscience Research. 88(1). 202–213. 25 indexed citations
15.
Bohl, Delphine, Song Liu, Stéphane Blanchard, et al.. (2008). Directed Evolution of Motor Neurons from Genetically Engineered Neural Precursors. Stem Cells. 26(10). 2564–2575. 25 indexed citations
16.
Blanchard, Stéphane, Michaël Hocquemiller, Georg Haase, et al.. (2006). Forced expression of the motor neuron determinant HB9 in neural stem cells affects neurogenesis. Experimental Neurology. 198(1). 167–182. 19 indexed citations
17.
Vitry, Sandrine, et al.. (2006). α-l-Iduronidase transport in neurites. Molecular Genetics and Metabolism. 87(4). 349–358. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026